The NIS-loaded exosomes increase the amount of NIS protein on the plasma membrane of liver cancer cells, which facilitate radioiodine uptake and consequently promotes 131I internal radiotherapy.130 The results proved significantly greater antitumor effect of 131I radionuclide therapy following exosome NIS delivery. This evidence concerns the gene SLC5A5 and liver cancer.